NRG GY007

Primary Category:

Surgical Protocols, Treatment Protocols

Disease Category:

Gynecologic, Ovarian, Ovarian Metastatic

Status:

New, Open

A Phase I/II Study of Ruxolitinib with Front-Line Neoadjuvant and Post-Surgical Therapy in Patients with Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT#02713386

Study open to Phase II accrual.

This protocol has additional regulatory requirements to be completed prior to registering any patients at your site.  Please contact Amber Boerner at 406-969-6067 or aboerner@mtcancer.org for additional information.